Ordenar

Buscar

01/08/2025 48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial
de Lazzari, E, Di Gregorio, S, Rojas, J, Curran, A, Domingo, P, Negredo, E, Tiraboschi, J, Gonzalez-Cordon, A, Torres, B, Sempere, A, Inciarte, A, Gatell, JM, Blanco, JL, Martinez, E. 48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2025; 80(8)DOI:10.1093/jac/dkaf192. PMID:40556520. IF:3.600(Q2/3D).
01/08/2025 A randomized study of 2 risk assessment models for individualized breast cancer risk estimation
López-Fernández, A, Duran-Lozano, L, Villacampa, G, Pardo, M, Pérez, E, Darder, E, Vallmajó, A, Alfonso, R, Cruellas, M, Roqué, A, Cartró, M, Bareas, A, Carrasco, E, Rezqallah, A, Jimenez-Macedo, AR, Torres-Esquius, S, Torres, M, Lopez, C, Espinosa, M, Teulé, A, Munté, E, Tuset, N, Diez, O, Feliubadaló, L, Lázaro, C, Llort, G, Carver, T, Ficorella, L, Mavaddat, N, Mercadé, A, Antoniou, AC, Brunet, J, Cajal, TRY, Balmaña, J. A randomized study of 2 risk assessment models for individualized breast cancer risk estimation. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2025; 117(8)DOI:10.1093/jnci/djaf067. PMID:40170233. IF:7.200(Q1/2D).
01/08/2025 Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma
van der Heijden, MS, Powles, T, Gupta, S, Loriot, Y, Galsky, MD, Valderrama, BP, Sridhar, SS, Yu, EY, Iyer, G, Kikuchi, E, Castellano, D, Hoffman-Censits, J, Drakaki, A, Mar, N, Rey, JPM, Vulsteke, C, Arafat, W, Duran, I, Dawson, NA, Swami, U, Gorla, S, Moreno, BH, Yu, X, Lu, YT, Bedke, J. Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma. ESMO Open. 2025; 10(8)DOI:10.1016/j.esmoop.2025.105544. PMID:40795788. IF:8.300(Q1/2D).
01/08/2025 Primary Visceral Ewing Sarcoma (Gastric and Bladder) with KIT Expression: A Report of Two Patients and a Differential Diagnostic Approach
Chaachou-Charradi, A, Bagué, S, Medina, CM, Lavernia, J, Claramunt, R, Guerrero, JAL, Navarro, S, Llombart-Bosch, A, Williamson, SR, Machado, I. Primary Visceral Ewing Sarcoma (Gastric and Bladder) with KIT Expression: A Report of Two Patients and a Differential Diagnostic Approach. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY. 2025; 33(5)DOI:10.1177/10668969241308205. PMID:39865727. IF:1.000(Q3/8D).
01/08/2025 To proceed or delay? The dilemma of community-acquired respiratory viruses in adults and pediatrics before allogeneic stem cell transplantation and chimeric-antigen-receptor T-cell therapy
Pinana, JL, Martino, R, Cesaro, S, Averbuch, D, Lujgman, P. To proceed or delay? The dilemma of community-acquired respiratory viruses in adults and pediatrics before allogeneic stem cell transplantation and chimeric-antigen-receptor T-cell therapy. CURRENT OPINION IN INFECTIOUS DISEASES. 2025; 38(4)DOI:10.1097/QCO.0000000000001120. PMID:40471062. IF:4.000(Q1/2D).
01/08/2025 A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE)
Camps-Renom, P, Guasch-Jiménez, M, Martinez-Domeño, A, Prats-Sánchez, L, Ramos-Pachón, A, Alvarez-Cienfuegos, J, Silva, Y, Fortea-Cabo, G, Morales-Caba, L, Rodríguez-Campello, A, Giralt-Steinhauer, E, Flores, A, Ustrell, X, López-Hernández, N, Corona-García, DJ, Freijo-Guerrero, MM, Luna, A, Tejada-Meza, H, Marta-Moreno, J, Moniche, F, Pardo-Galiana, B, Castellanos, M, Albert-Lacal, L, Sanz-Monllor, A, Aguilera-Simón, A, Marín, R, Ezcurra-Díaz, G, Lambea-Gil, A, Marti-Fàbregas, J. A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE). CEREBROVASCULAR DISEASES. 2025; 54(4)DOI:10.1159/000540606. PMID:39208776. IF:1.500(Q3/8D).
01/08/2025 Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study
García-Alfonso, P, Jimenez-Fonseca, P, Soto-Alsar, J, Baraibar, I, Santos, C, La Casta, A, Ghanem, I, Cortijo, G, Méndez, A, Pazo-Cid, R, Vera, R, Melián, M, Alcaide, J, Graña, B, Páez, D, Gallego, I, Lobo, M, Borregón, M, Montes, A, de Castro, E, Carmona-Bayonas, A, Aranda, E. Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study. ONCOLOGIST. 2025; 30(8)DOI:10.1093/oncolo/oyae300. PMID:39550209. IF:4.200(Q2/3D).
01/08/2025 Performance of computed tomography and magnetic resonance morphometry in evaluating brain atrophy in Down syndrome
Sánchez-Moreno, B, Zhang, LD, Salaberry, AC, Rozalem-Aranha, M, Moldenhauer, F, Brudfors, M, Ashburner, J, Nachev, P, de Asúa, DR, Strange, BA. Performance of computed tomography and magnetic resonance morphometry in evaluating brain atrophy in Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(8)DOI:10.1002/alz.70296. PMID:40762120. IF:11.100(Q1/1D).